WO1995003087A1 - Method and apparatus for defibrillation using a multiphasic truncated exponential waveform - Google Patents

Method and apparatus for defibrillation using a multiphasic truncated exponential waveform Download PDF

Info

Publication number
WO1995003087A1
WO1995003087A1 PCT/US1994/007752 US9407752W WO9503087A1 WO 1995003087 A1 WO1995003087 A1 WO 1995003087A1 US 9407752 W US9407752 W US 9407752W WO 9503087 A1 WO9503087 A1 WO 9503087A1
Authority
WO
WIPO (PCT)
Prior art keywords
shock
duration
heart
electrodes
phase
Prior art date
Application number
PCT/US1994/007752
Other languages
French (fr)
Inventor
Stephen J. Hahn
David K. Swanson
Original Assignee
Cardiac Pacemakers, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiac Pacemakers, Inc. filed Critical Cardiac Pacemakers, Inc.
Priority to AU73287/94A priority Critical patent/AU7328794A/en
Publication of WO1995003087A1 publication Critical patent/WO1995003087A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3956Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3906Heart defibrillators characterised by the form of the shockwave

Definitions

  • the present invention relates, generally, to the field of defibrillators. More particularly, it relates to an improvement in the efficacy of cardioverter-defibrillators (ICD) .
  • ICD cardioverter-defibrillators
  • AICDs Automatic implantable cardioverter-defibrillators
  • ICDs customarily include a sensor and sensing circuit to determine when a therapeutic shock is needed, a control circuit to determine what type of therapeutic shock is appropriate, a long-term energy source, such as a battery, a short-term energy storage means such as high-voltage capacitor, and a circuit for transferring electrical energy first from the battery to the capacitor and then from the capacitor to the heart by discharging the capacitor in waveforms having particular shapes, durations, and sequences, to electrodes which deliver the energy as a shock to a heart which is to be converted.
  • a sensor and sensing circuit to determine when a therapeutic shock is needed
  • a control circuit to determine what type of therapeutic shock is appropriate
  • a long-term energy source such as a battery
  • a short-term energy storage means such as high-voltage capacitor
  • Contoured Epicardial Electrodes and Biphasic Waveforms by Ellen G. Dixon, circulation 76, No. 5, 1176-1184, 1987, is primarily concerned with the testing of large contoured patch electrodes on dogs.
  • the electrodes were tested with monophasic, biphasic, and triphasic waveforms. Further, the biphasic waveforms were tested with the first phase being both longer than and shorter than the second phase. It is reported that biphasic waveforms, with the durations of the first and second phases equal, have a significantly lower threshold voltage than a monophasic waveform.
  • the defibrillation threshold voltage and energy were reported to be significantly higher for biphasic waveforms in which the relationship of the duration of the first to the second phase were 25/75 and 35/65, compared to 50/50, even though the initial voltage of the first phase was of a greater magnitude than the second, with the trailing voltage of the first phase being equal to the beginning voltage of the second phase.
  • biphasic shocks with P 1 (initial positive phase) longer than P 2 (terminal negative phase) markedly reduced energy requirements for nonthoracotomy canine defibrillation and may, therefore, facilitate development of nonthoracotomy devices for clinical applications.
  • the paper further reports that biphasic pulses with the second phase longer than the first phase (25 and 75% and 10 and 90% configurations) resulted in energy thresholds that were significantly higher than even those for monophasic shocks.
  • U.S. Patent No. 4,821,723 - issued April 18, 1989, and entitled: BIPHASIC WAVEFORMS FOR DEFIBRILLATION is directed toward a method and apparatus for defibrillating a heart with a biphasic shock having an initial phase, the duration of which is at least slightly greater than the duration of the second phase. Further, the first phase of the biphasic waveform commences with a voltage magnitude equal to or greater than the initial voltage level of the second phase.
  • U.S. Patent No. 5,083,562 issued on January 28, 1992, and entitled: METHOD AND APPARATUS FOR APPLYING ASYMMETRIC BIPHASIC TRUNCATED EXPONENTIAL COUNTERSHOCKS, sets forth a defibrillation therapy in which a first truncated exponential waveform of a first polarity has a first phase start amplitude and a first phase end amplitude and, a second truncated exponential waveform of second polarity opposite that of the first polarity, has a second phase start amplitude and a second phase end amplitude.
  • the second phase start amplitude being lower than the first phase start amplitude and in a disclosed embodiment being substantially equal to the first end amplitude.
  • the second phase start amplitude is equal to substantially one half of the first phase start amplitude.
  • This patent further teaches that the first and second phases are preferably of equal duration. While there are many patents and papers in addition to those set forth above which relate to biphasic waveforms, the inventor is unaware of any which teach the advantage of the first phase being shorter than the second. SUMMARY OF THE INVENTION It is an object of this invention to provide a method and apparatus for improving the efficacy of defibrillators which provide biphasic truncated exponential waveforms.
  • a method and apparatus of defibrillation in which multiphasic pulses are applied to a heart with the first pulse being of a shorter duration than the second pulse. More particularly, in accordance with this invention, a defibrillator is provided wherein a biphasic, truncated exponential waveform is generated from a single capacitor discharge in which the first pulse is shorter in duration than the subsequent phase or phases. Further, a method of defibrillation is provided wherein a defibrillator provides a biphasic pulse, the duration ratio of the first pulse to the subsequent pulse in a preferred embodiment being approximately 40 to 60.
  • the method and apparatus of this invention is generally applicable to converting arrhythmias of the heart, particularly both atrial and ventricular tachycardia arrhythmias.
  • FIG. l shows the exponentially decaying waveform of a capacitor discharge into a resistive load.
  • FIG. 2 shows a similar exponentially decaying waveform of the discharge of a capacitor into a resistive load, but which has been truncated.
  • FIG. 3 shows the typical biphasic waveform of the output of a defibrillator in accordance with the teachings of the prior art as set forth above.
  • FIG. 4 shows the biphasic waveform generated by a defibrillator in accordance with this invention.
  • FIG. 5 is a block diagram of a pulse generator for an implantable defibrillator which is capable of delivering biphasic truncated exponential waveform in accordance with this invention.
  • FIG. 6 is a biphasic defibrillator waveform in accordance with this invention such as could be delivered by the generator of FIG. 5.
  • FIG. 7 is a chart setting forth the probability of a successful defibrillation while varying the relative durations of first and second phases of an 80% tilt biphasic waveform with the overall waveform length being held at a constant 20 milliseconds.
  • FIG. 8 is a chart comparing the energy required for successful defibrillation for 80% tilt waveforms of four different fixed durations with the duration of the first phase with respect to the second phase being 40/60% in accordance with this invention, and 60/40% a now generally accepted duration relationship.
  • FIG. 9 is a chart comparing energy requirements with respect to the switching point from first to second phase as a percentage of peak voltage for a biphasic waveform.
  • duration D 1 is typically equal to duration D 2 , or longer, such as the 50/50% relationship shown in FIG. 3.
  • a biphasic defibrillation waveform such as shown in FIG. 3 may be generated by any number of circuits, one of which is set forth in Patent No. 4,850,357 issued July 25, 1989 and assigned to the assignee of this application.
  • the teachings of this patent while briefly set forth hereinafter, are incorporated herein by reference as an example of the type of circuit which might be used in practicing the teachings of this invention.
  • biphasic waveforms have most frequently been used with the initial voltage of the second phase equal to the terminal voltage of the first phase, such that considerably less energy is conveyed through the electrodes to the heart by the second phase as compared to the first phase.
  • This type of biphasic waveform facilitates the use of a single energy storage capacitor.
  • the initial amplitudes of each phase could be of equal magnitude or in any desired ratio of magnitudes.
  • the defibrillation efficacy of biphasic waveform pulses are improved by making the first phase shorter than the second. That is it has been determined, for instance, that the waveform shown in FIG. 4, wherein D., and D 2 are 40% and 60% respectively of the total pulse duration, has lower defibrillation strength requirements than the previously used biphasic waveform having equal first and second phases as is shown in FIG. 3, or longer first phases.
  • a biphasic pulse generator of the type shown in the above-mentioned Patent No. 4,850,357 may, through circuit component adjustments, deliver pulses in accordance with the applicant's invention. However, the same has not been previously done, wherein to do so was contrary to that which has been consistently taught in the prior art.
  • FIG. 5 a block diagram of a biphasic pulse generator of the type set forth in the just mentioned patent is shown.
  • Control circuit 10 is a Four State Sequencer specifically designed to provide a first wait duration D UI , a first pulse duration D 1f a second wait duration D u2 , and a second pulse duration D 2 by monitoring the voltage on capacitor 12 and providing timed signals to electronic switches 14 and 16 via drive circuits 18 and 20 respectively.
  • An output waveform from the circuit of FIG. 5 in accordance with this invention is shown in FIG. 6.
  • drive circuit 18 When drive circuit 18 is set high, the electronic switch 14 is allowed to conduct and a thyristor 22 is turned “on", such that the charge stored on capacitor 12 is delivered to the heart across electrodes 24 and 26 in a first polarity.
  • drive circuit 18 After a first phase duration D, as determined by output sense circuit 28, drive circuit 18 is forced low turning off electronic switch 14 and thyristor 22.
  • drive circuit 20 After a short delay D w2 , preferably less than 500 milliseconds, drive circuit 20 is set high turning on electronic switch 16 and a thyristor 30 thus, providing current of the opposite polarity to the heart.
  • second phase duration D 2 determined by output sense circuit 28 the electronic switch 16 is turned off which turns off thyristor 30. While the circuit of FIG. 5 is shown to provide wait durations D w1 and D w2 in FIG. 6, the duration D w2 being significantly less than D, or D 2 , it is not shown in the waveform of FIGS. 1-4.
  • the electronic switch 14 conducts to steer the low voltage side of the main storage capacitor 12 to electrode 26 while the high side is connected to electrode 24.
  • Electronic switch 16 conducts to steer the low voltage side of the main storage capacitor 12 to electrode 24 while the high side is connected to electrode 26.
  • the thyristor 22, when switch “on”, provides the high voltage to electrode 24.
  • the thyristor 30, when switched “on”, provides the high voltage to electrode 26.
  • Output sense circuit 28 monitors the output across electrodes 24 and 26. When the output voltage across electrodes 24 and 26 falls to a predetermined level, the output sense circuit 28 will signal the control circuit 10, which then forces drive circuit 18 low. This shuts off electronic switch 14 and, therefore, thyristor 22. When the voltage applied acros # s electrodes 24 and 26 falls to a still lower predetermined value, the output sense circuit 28 again signals the control circuit 10. This forces drive circuit 20 to be switched to a low, which shuts off electronic switch 16 and, therefore, the thyristor 30.
  • the high voltage isolation transformers 32 and 34 are used to isolate the thyristor drive circuits and prevent the transmission of undesired currents to them. Also, the high voltage isolation transformers are used to separate one section of the system from undesired influences of the other section.
  • the applicant has conducted studies with swine which establish the efficacy of a biphasic pulse having a shorter first phase in accordance with his invention.
  • specific groups of different biphasic defibrillation waveforms were applied to each swine, with the data used to fit defibrillation probability of success curves for each waveform in each swine.
  • the fifty percent probability of success was obtained for each waveform from the curves. Using appropriate statistical tests, the fifty percent probability of success levels were compared for significant differences. Six swine were tested in each study.
  • FIG. 7 is a bar chart showing the results of a study comparing the energy levels required for 50% probability of successful defibrillation for 20 millisecond, 80% tilt biphasic waveforms, wherein the duration of the first phase of the waveform was 4, 8 or 12 milliseconds.
  • the length of each bar and the values above each bar represent a normalized value of the energy required for the 50% probability of successful defibrillation under otherwise like conditions.
  • the 80% tilt referred to in FIG. 7 is determined by dividing the difference between the initial voltage and the final voltage by the initial voltage and expressing that value as a percentage. That is, if the initial voltage is 100 and the final voltage is 20, the tilt is 80%.
  • V p is the initial (or peak) voltage and V ⁇ is the final (or trailing) voltage of the waveforms.
  • V ⁇ is the final (or trailing) voltage of the waveforms.
  • a minimum of 10 milliseconds duration for the first phase has been commonly used. This was based upon the teachings of the prior art that the first phase should be equal to or longer than the second.
  • FIG. 7 for a very short first phase duration, that is 4 milliseconds, the energy levels required for successful defibrillation were increased dramatically over that for a 12 millisecond first phase duration as used in the past. However, a significantly lower energy level resulted when comparing the previously used 12 millisecond first phase to an 8 millisecond first phase in accordance with this invention. This difference was statistically significant at the p ⁇ .05 level.
  • FIG. 8 is a bar chart showing the results of a study conducted with 6 swine which considered biphasic waveforms of 5, 10, 15 and 20 milliseconds total durations and 80% tilt.
  • the energy requirements for the 40-60% first phase to second phase durations of this invention were compared to those for 60-40% durations used in the past at each of the four total durations.
  • the length of each of the bars and the values above each bar in FIG. 8 represents a per unit value of the energy required for fifty percent probability of successful defibrillation under otherwise like conditions.
  • the pulse durations shown in milliseconds are the total durations for the biphasic waveforms.
  • FIG. 9 is a bar chart showing the results of a study conducted with 6 swine which considered biphasic waveforms having a fixed 10 millisecond total duration and an 80% tilt.
  • the switch point between the first and second phase was varied and is expressed in the bar chart of FIG. 9 as occurring at a certain percentage of the initial voltage.
  • the length of each bar and the value above each bar in FIG. 9 represents the value of the energy required for the same probability of successful defibrillation under otherwise like conditions normalized to the energy value at the 40% of peak voltage switching point.
  • the switching point at 40% results in the previously used 60/40% biphasic waveform. Switching points greater than 40% decrease the relative duration of the first phase and increase the relative duration of the second phase. As shown in FIG. 9, increasing the switching point to 50% results in a 26% lower energy requirement than the previously used 40% switching point.
  • the 50% of peak voltage switching point yields the preferred 40/60% biphasic waveform ratio in accordance with this invention.
  • the switching point in accordance with the previously used 60/40% ratio is at 40% of the initial voltage.
  • a preferred value of the switching point is at 50% of the initial voltage.
  • the termination voltage is determined by output sense circuit 28 as a percentage of the initial voltage which would remain unchanged at 20% of the initial value of V.
  • Biphasic truncated exponential pulses in accordance with this invention may also be provided by pulse generators wherein the relative durations of the first and second pulses are determined by a ratio-metric control circuit. That is, the first phase is still terminated at a voltage determined as a percentage of the initial voltage, but the duration of the first phase is measured and the second phase is terminated when its duration reaches a certain percentage of the duration of the first phase.
  • a pulse generator is set forth in copending Appln. Serial No. 07/951,232, filed September 25, 1992, entitled METHOD AND APPARATUS FOR GENERATING MULTIPHASIC DEFIBRILLATION WAVEFORMS BASED ON PULSE WIDTH RATIOS. which is assigned to the assignee of this application, and the teachings of which application are incorporated herein by reference.
  • an improved method and apparatus for defibrillation of a heart is provided.
  • the defibrillation method of this invention has improved performance characteristics, such that a defibrillator operated in accordance with this invention may be made smaller, compared to prior art defibrillations, the defibrillator safety margin may be increased and a higher implant success rate realized due to the more efficacious therapy provided by the invention.
  • this invention is not limited to defibrillation applications, but is generally applicable to converting arrhythmias of the heart, particularly both atrial and ventricular tachycardia arrhythmias.
  • cardioverting shocks in accordance with this invention may be applied to the heart through either internal or external electrodes.

Abstract

A method and apparatus for converting an arrhythmia of a heart using a biphasic truncated exponential waveform wherein the first phase is of shorter duration than the second phase.

Description

METHOD AND APPARATUS FOR DEFIBRILLATION USING A MULTIPHASIC TRUNCATED EXPONENTIAL WAVEFORM
BACKGROUND OF THE INVENTION 1. FIELD OF THE INVENTION The present invention relates, generally, to the field of defibrillators. More particularly, it relates to an improvement in the efficacy of cardioverter-defibrillators (ICD) . Automatic implantable cardioverter-defibrillators (AICDs) or ICDs customarily include a sensor and sensing circuit to determine when a therapeutic shock is needed, a control circuit to determine what type of therapeutic shock is appropriate, a long-term energy source, such as a battery, a short-term energy storage means such as high-voltage capacitor, and a circuit for transferring electrical energy first from the battery to the capacitor and then from the capacitor to the heart by discharging the capacitor in waveforms having particular shapes, durations, and sequences, to electrodes which deliver the energy as a shock to a heart which is to be converted.
Development of implantable cardioverter-defibrillators since their introduction in the mid 1980s, has not only been directed toward improving their reliability in terms of delivering defibrillation pulses when fibrillation of the heart is detected, but also toward increasing their efficacy. That is, to apply to a heart the minimum amount of energy necessary to ensure conversion. By decreasing the amount of energy required for conversion or defibrillation, the physical size of the implanted automatic defibrillator can be decreased by reducing the physical size of the battery, the capacitor, and other components. A decrease in energy requirements also means that even if the defibrillator is with some degree of frequency called upon to defibrillate a heart, the battery will have a longer life. Thus, extending the period of time before which the defibrillator must be replaced. Advances in reducing the energy required for defibrillation have been made in the past in various ways. The electrodes delivering the defibrillation shocks to the heart have been improved. It has also been found that shocks of particular shapes, durations, and polarities are more effective in defibrillating the heart. This invention relates to further improvements in the shape of the shocks.
2. DESCRIPTION OF RELATED ART INCLUDING INFORMATION DISCLOSED UNDER SECS. 1.97-1.99
In a paper entitled: DECREASED DEFIBRILLATOR-INDUCED DYSFUNCTION WITH BIPHASIC RECTANGULAR WAVEFORMS: by Janice L. Jones and Ronald E. Jones, AM. J. Physiol. 247 (Heart Circ. Physiol. 16); H792-H796, 1984, a study is reported on the characteristics of the negative second portion of a biphasic waveform which best ameliorates postshock dysfunction. The study was based on the use of chick embryo cultured myocardial cells. The article concluded that "the negative tail can only partially reverse the deleterious effects of the leading portion of the waveform and that this effect can be produced either by a low amplitude undershoot that lasts for a long time or by a higher amplitude undershoot that lasts for a shorter time." While this work did find that some waveshapes with the second phase longer than the first reduced dysfunction, dysfunction has never been shown to have a impact on defibrillation efficacy. The paper Improved Defibrillation Thresholds with Large
Contoured Epicardial Electrodes and Biphasic Waveforms; by Ellen G. Dixon, circulation 76, No. 5, 1176-1184, 1987, is primarily concerned with the testing of large contoured patch electrodes on dogs. The electrodes were tested with monophasic, biphasic, and triphasic waveforms. Further, the biphasic waveforms were tested with the first phase being both longer than and shorter than the second phase. It is reported that biphasic waveforms, with the durations of the first and second phases equal, have a significantly lower threshold voltage than a monophasic waveform. Furthermore, the defibrillation threshold voltage and energy were reported to be significantly higher for biphasic waveforms in which the relationship of the duration of the first to the second phase were 25/75 and 35/65, compared to 50/50, even though the initial voltage of the first phase was of a greater magnitude than the second, with the trailing voltage of the first phase being equal to the beginning voltage of the second phase.
Thus, while this paper was primarily directed to research with respect to electrodes, it does present data indicating that the duration of the first phase of a biphasic waveform should be equal to or longer than that of the second phase. This conclusion was based upon an earlier postulation by Jones et al that the first phase conditions the heart cells to allow more effective defibrillation by the second phase. The paper, Comparative Efficacy of Monophasic and
Biphasic Truncated Exponential Shocks for Nonthoracotomv Internal Defibrillation in Dogs; by Peter D. Chapman, et al, Journal of the American College of Cardiology, Vol. 12, No. 3, September 1988 pages 739-745, reports the efficacies of monophasic and biphasic truncated exponential shocks in dogs. The monophasic shocks were compared with biphasic shocks having relative P1 (first phase) versus P2 (second phase) durations of (50 and 50%, 75 and 25%, 90 and 10%, 25 and 75%, 10 and 90%) . It was concluded that biphasic shocks with P1 (initial positive phase) longer than P2 (terminal negative phase) markedly reduced energy requirements for nonthoracotomy canine defibrillation and may, therefore, facilitate development of nonthoracotomy devices for clinical applications. The paper further reports that biphasic pulses with the second phase longer than the first phase (25 and 75% and 10 and 90% configurations) resulted in energy thresholds that were significantly higher than even those for monophasic shocks.
The paper: Optimal Biphasic Waveform Morphology for Canine Cardiac Defibrillation with a Transvenous Catheter and Subcutaneous Patch System, by John C. Schuder, et al, Circulation, vol 78, 11-219, 1988 set forth that previous studies have shown that biphasic waveforms are generally superior to monophasic waveforms for achieving canine ventricular defibrillation. It further reports on additional tests directed at determining the significance of the duration of the initial phase. All of the tests for this study were conducted with a 10 millisecond truncated exponential waveform shock, and with the final current equal to 25% of the initial current. The timing of the polarity reversal was changed such that initial pulse durations of 1, 3, 5, 7 and 9 milliseconds were tested. The study concluded that ten millisecond biphasic truncated exponential waveforms are more effective with an initial pulse duration of 5 to 7 milliseconds, i.e., equal to or greater than the duration of the second phase.
U.S. Patent No. 4,850,357 - issued July 25, 1989, and entitled: BIPHASIC PULSE GENERATOR FOR AN IMPLANTABLE DEFIBRILLATOR; is directed toward a circuit for delivering biphasic pulses without the need to short circuit the high voltage capacitor, which stores the energy for the pulses, at the end of a pulse. While not elaborating on the relative durations of the first and second phases of the pulse, the phases are shown to be equal, with the initial voltage of the second phase being equal to the terminal voltage of the first phase.
U.S. Patent No. 4,821,723 - issued April 18, 1989, and entitled: BIPHASIC WAVEFORMS FOR DEFIBRILLATION is directed toward a method and apparatus for defibrillating a heart with a biphasic shock having an initial phase, the duration of which is at least slightly greater than the duration of the second phase. Further, the first phase of the biphasic waveform commences with a voltage magnitude equal to or greater than the initial voltage level of the second phase.
Referring to the paper: Transthoracic Ventricular Defibrillation in the 100 Kg calf with Symmetrical One-Cycle Bidirectional Rectangular Wave Stimuli; IEEE Trans Biomed. Eng. 30: 415, 1983, and to the paper: Defibrillator of 100-Kg Calves with Asymmetrical, Bidirectional Rectangular Pulses; Cardiovasa Res. 419, 1984, it is stated in U.S. Patent No. 4,821,723 that: "Schuder and his associates were able to defibrillate 100 kg calves using symmetrical biphasic rectangular waveforms at a lower range of energy and current, and to achieve a higher percentage of successful first shock defibrillations than with monophasic waveforms...Those same investigators obtained good results with asymmetrical biphasic waveforms in which the amplitude of the second phase of the shock was smaller than that of the first phase. and the two phases were of equal duration." This patent also sets forth the theory that the duration of the first phase of a biphasic waveform may have a significant effect on the extent of conditioning. It is further stated: "It appears that a short first phase, relative to the second phase, may be of insufficient duration to allow a conditioning process to be completed." As was previously set forth with respect to the Dixon paper, this study is based on the earlier postulation by Jones et al that the first phase conditions the heart cells to allow more effective defibrillation by the second phase.
Other efforts to reduce the size of an implantable defibrillator have been directed toward improvement of the electrodes through which pulses are applied to the heart for defibrillation purposes. U.S. Patent No. 4,953,551 - issued on September 4, 1990 and entitled: METHOD OF DEFIBRILLATING A HEART, is primarily directed toward an improvement in the electrodes. However, the patent also advocates the use of an asymmetrical biphasic waveform. The asymmetrical waveform set forth is one in which the first and second phase, are of equal duration, but in which the initial voltage of the second phase is equal to the final voltage of the first phase, (voltage decays during the pulses on an exponential basis) .
U.S. Patent No. 4,998,531 - issued on March 12, 1991, and entitled: IMPLANTABLE N-PHASIC DEFIBRILLATOR OUTPUT BRIDGE CIRCUIT discloses a means for generating not only biphasic, but also mono¬ phasic, multi-phase or sequential defibrillation pulses. The patent is not particularly concerned with, nor does it discuss, the efficacy of biphasic pulses nor is it concerned with the relative durations of the first and second pulses.
U.S. Patent No. 5,083,562 issued on January 28, 1992, and entitled: METHOD AND APPARATUS FOR APPLYING ASYMMETRIC BIPHASIC TRUNCATED EXPONENTIAL COUNTERSHOCKS, sets forth a defibrillation therapy in which a first truncated exponential waveform of a first polarity has a first phase start amplitude and a first phase end amplitude and, a second truncated exponential waveform of second polarity opposite that of the first polarity, has a second phase start amplitude and a second phase end amplitude. The second phase start amplitude being lower than the first phase start amplitude and in a disclosed embodiment being substantially equal to the first end amplitude. Further, the second phase start amplitude is equal to substantially one half of the first phase start amplitude. This patent further teaches that the first and second phases are preferably of equal duration. While there are many patents and papers in addition to those set forth above which relate to biphasic waveforms, the inventor is unaware of any which teach the advantage of the first phase being shorter than the second. SUMMARY OF THE INVENTION It is an object of this invention to provide a method and apparatus for improving the efficacy of defibrillators which provide biphasic truncated exponential waveforms. It is a further object of the method of this invention to provide biphasic defibrillation pulses to a heart wherein the relative durations of the phases have a predetermined relationship to each other, such that the energy, voltage, and current required for defibrillation is reduced from that required prior to the applicant's invention. It is a further object of this invention to provide a defibrillator which generates biphasic defibrillation pulses in accordance with the applicant's invention wherein the energy, voltage, and current required for defibrillation is reduced from that which has previously been considered necessary.
In accordance with this invention, a method and apparatus of defibrillation is provided in which multiphasic pulses are applied to a heart with the first pulse being of a shorter duration than the second pulse. More particularly, in accordance with this invention, a defibrillator is provided wherein a biphasic, truncated exponential waveform is generated from a single capacitor discharge in which the first pulse is shorter in duration than the subsequent phase or phases. Further, a method of defibrillation is provided wherein a defibrillator provides a biphasic pulse, the duration ratio of the first pulse to the subsequent pulse in a preferred embodiment being approximately 40 to 60.
In its broader aspects the method and apparatus of this invention is generally applicable to converting arrhythmias of the heart, particularly both atrial and ventricular tachycardia arrhythmias.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. l shows the exponentially decaying waveform of a capacitor discharge into a resistive load. FIG. 2 shows a similar exponentially decaying waveform of the discharge of a capacitor into a resistive load, but which has been truncated.
FIG. 3 shows the typical biphasic waveform of the output of a defibrillator in accordance with the teachings of the prior art as set forth above.
FIG. 4 shows the biphasic waveform generated by a defibrillator in accordance with this invention.
FIG. 5 is a block diagram of a pulse generator for an implantable defibrillator which is capable of delivering biphasic truncated exponential waveform in accordance with this invention.
FIG. 6 is a biphasic defibrillator waveform in accordance with this invention such as could be delivered by the generator of FIG. 5. FIG. 7 is a chart setting forth the probability of a successful defibrillation while varying the relative durations of first and second phases of an 80% tilt biphasic waveform with the overall waveform length being held at a constant 20 milliseconds. FIG. 8 is a chart comparing the energy required for successful defibrillation for 80% tilt waveforms of four different fixed durations with the duration of the first phase with respect to the second phase being 40/60% in accordance with this invention, and 60/40% a now generally accepted duration relationship. FIG. 9 is a chart comparing energy requirements with respect to the switching point from first to second phase as a percentage of peak voltage for a biphasic waveform.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT Generally, all current implantable defibrillation pulse generators and even some external generators use a capacitor discharge to deliver pulse energy to a heart to be defibrillated. The discharge of a charged capacitor into a resistive load, which is representative of a heart and attached defibrillation electrodes, results in a waveform with an exponential decay from a peak voltage Vp as shown in FIG. 1. When a capacitor discharge is used for defibrillation, prior experimentation has established that stopping or truncating the discharge at a voltage Vτ, before it reaches too low a level, as shown in FIG. 2, results in more efficacious defibrillation. Further, as set forth in the description of related art set forth above, it has been shown that causing a reversal of polarity during the discharge to produce a so-called biphasic waveform, as shown in FIG. 3, results in improved defibrillation efficacy as compared to a "monophasic" waveform such as shown in FIG. 2. Referring to FIG. 3, during the first phase, which has a duration D the discharge voltage decays from Vp to Vs. The polarity of the pulse applied to the heart is then reversed, with the voltage decaying during the second phase of a duration D2 from -Vs to -Vτ. In accordance with the prior art, duration D1 is typically equal to duration D2, or longer, such as the 50/50% relationship shown in FIG. 3. A biphasic defibrillation waveform such as shown in FIG. 3 may be generated by any number of circuits, one of which is set forth in Patent No. 4,850,357 issued July 25, 1989 and assigned to the assignee of this application. The teachings of this patent while briefly set forth hereinafter, are incorporated herein by reference as an example of the type of circuit which might be used in practicing the teachings of this invention.
As set forth above in the description of related art, it has been the consensus of those skilled in the art that making the first phase of a biphasic waveform at least equal to or preferably longer in duration than the second phase provides the most effective defibrillation, all other parameters being the same. Further, biphasic waveforms have most frequently been used with the initial voltage of the second phase equal to the terminal voltage of the first phase, such that considerably less energy is conveyed through the electrodes to the heart by the second phase as compared to the first phase. This type of biphasic waveform facilitates the use of a single energy storage capacitor. However, if two capacitors are utilized, the initial amplitudes of each phase could be of equal magnitude or in any desired ratio of magnitudes.
The applicant has now determined, contrary to the teachings of the prior art as set forth above, that the defibrillation efficacy of biphasic waveform pulses are improved by making the first phase shorter than the second. That is it has been determined, for instance, that the waveform shown in FIG. 4, wherein D., and D2 are 40% and 60% respectively of the total pulse duration, has lower defibrillation strength requirements than the previously used biphasic waveform having equal first and second phases as is shown in FIG. 3, or longer first phases.
Having determined that the defibrillation strength requirements are lower with a shorter first phase, it is now possible: to reduce the size of the pulse generator, to increase the defibrillator safety margin, to provide a therapy which is more easily tolerated by the patient and to provide a higher implant success rate due to the more efficacious therapy, particularly when endocardial leads are used. A biphasic pulse generator of the type shown in the above-mentioned Patent No. 4,850,357 may, through circuit component adjustments, deliver pulses in accordance with the applicant's invention. However, the same has not been previously done, wherein to do so was contrary to that which has been consistently taught in the prior art.
Referring to FIG. 5, a block diagram of a biphasic pulse generator of the type set forth in the just mentioned patent is shown. FIG. 5 corresponds in general to FIG. 2 of the just mentioned patent. Control circuit 10 is a Four State Sequencer specifically designed to provide a first wait duration DUI, a first pulse duration D1f a second wait duration Du2, and a second pulse duration D2 by monitoring the voltage on capacitor 12 and providing timed signals to electronic switches 14 and 16 via drive circuits 18 and 20 respectively. An output waveform from the circuit of FIG. 5 in accordance with this invention is shown in FIG. 6. When drive circuit 18 is set high, the electronic switch 14 is allowed to conduct and a thyristor 22 is turned "on", such that the charge stored on capacitor 12 is delivered to the heart across electrodes 24 and 26 in a first polarity. After a first phase duration D, as determined by output sense circuit 28, drive circuit 18 is forced low turning off electronic switch 14 and thyristor 22. After a short delay Dw2, preferably less than 500 milliseconds, drive circuit 20 is set high turning on electronic switch 16 and a thyristor 30 thus, providing current of the opposite polarity to the heart. After second phase duration D2 determined by output sense circuit 28, the electronic switch 16 is turned off which turns off thyristor 30. While the circuit of FIG. 5 is shown to provide wait durations Dw1 and Dw2 in FIG. 6, the duration Dw2 being significantly less than D, or D2, it is not shown in the waveform of FIGS. 1-4.
In summary, the electronic switch 14 conducts to steer the low voltage side of the main storage capacitor 12 to electrode 26 while the high side is connected to electrode 24. Electronic switch 16 conducts to steer the low voltage side of the main storage capacitor 12 to electrode 24 while the high side is connected to electrode 26. The thyristor 22, when switch "on", provides the high voltage to electrode 24. The thyristor 30, when switched "on", provides the high voltage to electrode 26.
Output sense circuit 28 monitors the output across electrodes 24 and 26. When the output voltage across electrodes 24 and 26 falls to a predetermined level, the output sense circuit 28 will signal the control circuit 10, which then forces drive circuit 18 low. This shuts off electronic switch 14 and, therefore, thyristor 22. When the voltage applied acros#s electrodes 24 and 26 falls to a still lower predetermined value, the output sense circuit 28 again signals the control circuit 10. This forces drive circuit 20 to be switched to a low, which shuts off electronic switch 16 and, therefore, the thyristor 30.
The high voltage isolation transformers 32 and 34 are used to isolate the thyristor drive circuits and prevent the transmission of undesired currents to them. Also, the high voltage isolation transformers are used to separate one section of the system from undesired influences of the other section.
The applicant has conducted studies with swine which establish the efficacy of a biphasic pulse having a shorter first phase in accordance with his invention. As hereinafter set forth, specific groups of different biphasic defibrillation waveforms were applied to each swine, with the data used to fit defibrillation probability of success curves for each waveform in each swine. The fifty percent probability of success was obtained for each waveform from the curves. Using appropriate statistical tests, the fifty percent probability of success levels were compared for significant differences. Six swine were tested in each study.
STUDY 1 FIG. 7 is a bar chart showing the results of a study comparing the energy levels required for 50% probability of successful defibrillation for 20 millisecond, 80% tilt biphasic waveforms, wherein the duration of the first phase of the waveform was 4, 8 or 12 milliseconds. The length of each bar and the values above each bar represent a normalized value of the energy required for the 50% probability of successful defibrillation under otherwise like conditions. The 80% tilt referred to in FIG. 7 is determined by dividing the difference between the initial voltage and the final voltage by the initial voltage and expressing that value as a percentage. That is, if the initial voltage is 100 and the final voltage is 20, the tilt is 80%. Referring to FIGS 1-4, and 6 showing defibrillator waveforms, Vp is the initial (or peak) voltage and Vτ is the final (or trailing) voltage of the waveforms. Prior to the applicant's invention, for a waveform with a total duration of 20 milliseconds, a minimum of 10 milliseconds duration for the first phase has been commonly used. This was based upon the teachings of the prior art that the first phase should be equal to or longer than the second. As set forth in FIG. 7, for a very short first phase duration, that is 4 milliseconds, the energy levels required for successful defibrillation were increased dramatically over that for a 12 millisecond first phase duration as used in the past. However, a significantly lower energy level resulted when comparing the previously used 12 millisecond first phase to an 8 millisecond first phase in accordance with this invention. This difference was statistically significant at the p < .05 level.
STUDY 2 FIG. 8 is a bar chart showing the results of a study conducted with 6 swine which considered biphasic waveforms of 5, 10, 15 and 20 milliseconds total durations and 80% tilt. The energy requirements for the 40-60% first phase to second phase durations of this invention were compared to those for 60-40% durations used in the past at each of the four total durations. The length of each of the bars and the values above each bar in FIG. 8 represents a per unit value of the energy required for fifty percent probability of successful defibrillation under otherwise like conditions. The pulse durations shown in milliseconds are the total durations for the biphasic waveforms. It should be noted that the energy requirements at all four total durations are lower for the 40-60 ratio in accordance with this invention compared to those for the 60-40% waveforms previously used. Energy requirements are reduced an average of 30 percent. Statistically significant differences were found at the 10, 15 and 20 millisecond total durations pulses.
STUDY 3 FIG. 9 is a bar chart showing the results of a study conducted with 6 swine which considered biphasic waveforms having a fixed 10 millisecond total duration and an 80% tilt. The switch point between the first and second phase was varied and is expressed in the bar chart of FIG. 9 as occurring at a certain percentage of the initial voltage. The length of each bar and the value above each bar in FIG. 9 represents the value of the energy required for the same probability of successful defibrillation under otherwise like conditions normalized to the energy value at the 40% of peak voltage switching point. The switching point at 40% results in the previously used 60/40% biphasic waveform. Switching points greater than 40% decrease the relative duration of the first phase and increase the relative duration of the second phase. As shown in FIG. 9, increasing the switching point to 50% results in a 26% lower energy requirement than the previously used 40% switching point. The 50% of peak voltage switching point yields the preferred 40/60% biphasic waveform ratio in accordance with this invention.
In accordance with the teachings of the circuit shown in FIG. 5, the switching point in accordance with the previously used 60/40% ratio is at 40% of the initial voltage. In accordance with this invention, a preferred value of the switching point is at 50% of the initial voltage. Similarly, the termination voltage is determined by output sense circuit 28 as a percentage of the initial voltage which would remain unchanged at 20% of the initial value of V.
Biphasic truncated exponential pulses in accordance with this invention may also be provided by pulse generators wherein the relative durations of the first and second pulses are determined by a ratio-metric control circuit. That is, the first phase is still terminated at a voltage determined as a percentage of the initial voltage, but the duration of the first phase is measured and the second phase is terminated when its duration reaches a certain percentage of the duration of the first phase. Such a pulse generator is set forth in copending Appln. Serial No. 07/951,232, filed September 25, 1992, entitled METHOD AND APPARATUS FOR GENERATING MULTIPHASIC DEFIBRILLATION WAVEFORMS BASED ON PULSE WIDTH RATIOS. which is assigned to the assignee of this application, and the teachings of which application are incorporated herein by reference.
Thus, in accordance with this invention, an improved method and apparatus for defibrillation of a heart is provided. The defibrillation method of this invention has improved performance characteristics, such that a defibrillator operated in accordance with this invention may be made smaller, compared to prior art defibrillations, the defibrillator safety margin may be increased and a higher implant success rate realized due to the more efficacious therapy provided by the invention.
It should be apparent to those skilled in the art that what has been described is considered at present to be the preferred embodiment of the defibrillation method and apparatus of this invention. In accordance with the Patent Statutes, changes may be made in the defibrillation method and apparatus without actually departing from the true spirit and scope of this invention. For instance, this invention is applicable to any biphasic or multiphasic waveform, with different shapes, i.e., square, ramp, triangle, sinusoidal, etc., of various tilts, and without regard to the particular circuit which develops the waveform. In the case of multiphasic waveforms, the first phase would be shorter than either the second phase or a combination of ensuing phases including the second. Further, this invention is not limited to defibrillation applications, but is generally applicable to converting arrhythmias of the heart, particularly both atrial and ventricular tachycardia arrhythmias. Finally, cardioverting shocks in accordance with this invention may be applied to the heart through either internal or external electrodes.
The appended claims are intended to cover all such changes and modifications which fall in the true spirit and scope of this invention.

Claims

We claim:
1. A method for defibrillating a heart by applying electrical energy shocks to the heart through electrodes, the method comprising:
A. applying a first shock having a first duration and a first polarity to the heart through the electrodes,
B. applying at least a second shock, following said first shock, to the heart through the electrodes, said second shock having a second polarity opposite to said first polarity, and having a second duration which is longer than said first duration.
2. The method of claim 1, wherein the ratio of the duration of said first shock to the duration of said second shock is approximately two to three.
3. The method of claim 1, wherein said first and second shocks form a biphasic truncated exponential waveshape.
4. The method of claim 3, wherein said first shock terminates and said second shock begins with a magnitude of approximately 50 percent of the initial value of the first shock.
5. The method of claim 4 wherein the duration of the second shock is approximately 1.5 times the duration of the first shock.
6. The method of claim 3, wherein said second shock terminates with a magnitude of approximately 20 percent of the initial value of the first shock.
7. The method of claim 6, wherein the total duration of the biphasic truncated exponential waveform is between 2 and 20 milliseconds.
8. The method of claim 3, wherein the duration of said first shock is 8 milliseconds, and the total duration of each biphasic truncated exponential waveform is 20 milliseconds.
9. A method for defibrillating a heart by applying electrical energy shocks to the heart through electrodes, the method comprising:
A. applying a first shock having a first duration and a first average magnitude to the heart through the electrodes,
B. applying at least a second shock, following said first shock to the heart through the electrodes, said second shock having a second duration and a second average magnitude, said second duration being longer than said first duration and said second average magnitude being less than said first average magnitude.
10. A method for defibrillating a heart by applying electrical energy shocks to the heart through electrodes, the method comprising:
A. applying a first shock having a first duration and a first average magnitude to the heart, through the electrodes,
B. applying at least a second shock to the heart, through the electrodes following said first shock, said second shock having a second duration and a second average magnitude, said second duration being longer than said first duration, the total energy required to be delivered to the heart by said first and second shocks to cause defibrillation being less than that required when the first shock duration is longer than the second shock duration.
11. The method of claim 10, wherein said second average magnitude is less than said first average magnitude.
12. An electronic circuit for applying shocks through electrodes to a heart for the purpose of converting an arrhythmia of the heart,
said circuit delivering a first shock having a first duration to the heart through the electrodes, said circuit delivering at least a second shock, following said first shock, to the heart through the electrodes, said second shock having a second duration, said second duration being longer than said first duration.
13. An electronic circuit for applying shocks through electrodes to a heart for the purpose of converting an arrhythmia of the heart, said circuit delivering a first shock having a first duration and a first magnitude to the heart through the electrodes, said circuit delivering at least a second shock, following said first shock, to the heart, said second shock having a second duration and a second magnitude, said second duration being longer than said first duration, the total energy required to be delivered to the heart by said first and second shocks to cause conversion being less than that required when the first shock duration is longer than the second shock duration.
14. A system for converting an arrhythmia of a heart by applying electrical energy shocks to the heart, said system comprising:
A. a sensing means for sensing an arrhythmia of a heart,
B. a first shock delivery means for delivering a first shock of a first duration and a first average magnitude to the heart, C. a second shock delivery means for delivering a second shock of a second duration and a second average magnitude to the heart, said second duration being longer than said first duration.
15. The system of claim 14, wherein said second average magnitude is less than said first average magnitude.
16. The system of claim 14, wherein the ratio of the duration of said first shock to the duration of said second shock is approximately two to three.
17. The system of claim 14, wherein said first and second shocks form a biphasic truncated exponential waveshape.
18. The system of claim 17, wherein said first shock terminates and said second shock begins with a magnitude of approximately 50 percent of the initial value of the first shock.
19. The system of claim 17, wherein said second shock terminates with a magnitude of approximately 20 percent of the initial value of the first shock.
20. The system of claim 19, wherein the total duration of the biphasic truncated exponential waveform is between 2 and 20 milliseconds.
21. The system of claim 17, wherein the duration of said first shock is 8 milliseconds, and the total duration of each biphasic truncated exponential waveform is 20 milliseconds.
PCT/US1994/007752 1993-07-26 1994-07-12 Method and apparatus for defibrillation using a multiphasic truncated exponential waveform WO1995003087A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU73287/94A AU7328794A (en) 1993-07-26 1994-07-12 Method and apparatus for defibrillation using a multiphasic truncated exponential waveform

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/097,463 US5468254A (en) 1993-07-26 1993-07-26 Method and apparatus for defibrillation using a multiphasic truncated exponential waveform
US08/097,463 1993-07-26

Publications (1)

Publication Number Publication Date
WO1995003087A1 true WO1995003087A1 (en) 1995-02-02

Family

ID=22263489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/007752 WO1995003087A1 (en) 1993-07-26 1994-07-12 Method and apparatus for defibrillation using a multiphasic truncated exponential waveform

Country Status (3)

Country Link
US (1) US5468254A (en)
AU (1) AU7328794A (en)
WO (1) WO1995003087A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733310A (en) * 1996-12-18 1998-03-31 Zmd Corporation Electrotherapy circuit and method for producing therapeutic discharge waveform immediately following sensing pulse
US5769872A (en) * 1996-12-18 1998-06-23 Zmd Corporation Electrotherapy circuit and method for shaping current waveforms
US5797968A (en) * 1996-12-18 1998-08-25 Zmd Corporation Electrotherapy circuit for producing current waveform with sawtooth ripple
US5800463A (en) * 1996-12-18 1998-09-01 Zmd Corporation Electrotherapy circuit having controlled peak current
US5800462A (en) * 1996-12-18 1998-09-01 Zmd Corporation Electrotherapy circuit for producing therapeutic discharge waveform based on high-current sensing pulse
US5904706A (en) * 1996-12-18 1999-05-18 Zmd Corporation Method and apparatus for producing electrotherapy current waveform with ripple
US6096063A (en) * 1996-12-18 2000-08-01 Zmd Corporation Electrotherapy circuit having controlled current discharge based on patient-dependent electrical parameter
WO2009078942A3 (en) * 2007-12-13 2009-08-13 Cardiac Pacemakers Inc Defibrillation shock output circuit
US8433404B2 (en) 2009-05-19 2013-04-30 Cardiac Pacemakers, Inc. Integrated high voltage output circuit

Families Citing this family (234)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6343232B1 (en) 1966-08-19 2002-01-29 Mower Chf Treatment Irrevocable Trust Augmentation of muscle contractility by biphasic stimulation
US5534015A (en) * 1992-02-18 1996-07-09 Angeion Corporation Method and apparatus for generating biphasic waveforms in an implantable defibrillator
SE9303119D0 (en) * 1993-09-24 1993-09-24 Siemens Elema Ab defibrillator
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
IL125136A (en) 1996-01-08 2003-07-31 Impulse Dynamics Nv Electrical cardiac muscle controller method and apparatus
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
IL125424A0 (en) 1998-07-20 1999-03-12 New Technologies Sa Ysy Ltd Pacing with hemodynamic enhancement
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US5908442A (en) * 1996-04-12 1999-06-01 Survivalink Corporation Stepped truncated damped sinusoidal defibrillation waveform
WO1997038754A1 (en) * 1996-04-12 1997-10-23 Survivalink Corporation External defibrillator having low capacitance and small time constant
US5991658A (en) * 1996-07-01 1999-11-23 Survivalink Corporation Continual waveform shape reforming method and apparatus for transchest resistance dynamics
US7840264B1 (en) 1996-08-19 2010-11-23 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US6337995B1 (en) 1996-08-19 2002-01-08 Mower Chf Treatment Irrevocable Trust Atrial sensing and multiple site stimulation as intervention for atrial fibrillation
US6341235B1 (en) 1996-08-19 2002-01-22 Mower Chf Treatment Irrevocable Trust Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool
US7203537B2 (en) 1996-08-19 2007-04-10 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US6295470B1 (en) 1996-08-19 2001-09-25 The Mower Family Chf Treatment Irrevocable Trust Antitachycardial pacing
US7908003B1 (en) 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US6411847B1 (en) 1996-08-19 2002-06-25 Morton M. Mower Apparatus for applying cyclic pacing at an average rate just above the intrinsic heart rate
US8447399B2 (en) 1996-08-19 2013-05-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US7440800B2 (en) 1996-08-19 2008-10-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US5824017A (en) * 1997-03-05 1998-10-20 Physio-Control Corporation H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator
US6963773B2 (en) * 1997-03-05 2005-11-08 Medtronic Physio-Control Manufacturing Corp. H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator using single SCR and IGBT switches in an integrated package
US5873893A (en) * 1997-03-05 1999-02-23 Physio-Control Corporation Method and apparatus for verifying the integrity of an output circuit before and during application of a defibrillation pulse
US6175765B1 (en) 1997-03-05 2001-01-16 Medtronic Physio-Control Manufacturing Corp. H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator
US5995871A (en) * 1997-10-29 1999-11-30 Uab Research Foundation System and method for cardioversion using scan stimulation
US6067470A (en) * 1998-03-05 2000-05-23 Mower Family Chf Treatment Irrevocable Trust System and method for multiple site biphasic stimulation to revert ventricular arrhythmias
US6539255B1 (en) 1998-07-16 2003-03-25 Cardiac Science, Inc. Full-tilt exponential defibrillation waveform
US6208895B1 (en) * 1998-10-13 2001-03-27 Physio-Control Manufacturing Corporation Circuit for performing external pacing and biphasic defibrillation
EP2208782B1 (en) 1999-02-04 2017-05-31 Pluristem Ltd. Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
US6411845B1 (en) 1999-03-04 2002-06-25 Mower Chf Treatment Irrevocable Trust System for multiple site biphasic stimulation to revert ventricular arrhythmias
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
WO2000072912A1 (en) 1999-05-26 2000-12-07 Impulse Dynamics Nv Local cardiac motion control using applied electrical signals and mechanical force
US6304777B1 (en) 1999-05-26 2001-10-16 Impulse Dynamics N.V. Induction of cardioplegia applied electrical signals
US6285906B1 (en) * 1999-05-26 2001-09-04 Impulse Dynamics N. V. Muscle contraction assist device
DE19930267B4 (en) * 1999-06-25 2006-10-05 Biotronik Gmbh & Co. Kg defibrillator
US6738664B1 (en) 1999-09-24 2004-05-18 The Curators Of The University Of Missouri Method of and apparatus for atrial and ventricular defibrillation or cardioversion with an electrical waveform optimized in the frequency domain
DE60028923T2 (en) * 1999-09-24 2006-11-09 The Curators Of The University Of Missouri FLAMMING OR CARDIOVERSION WITH A WAVEFORM OPTIMIZED IN THE FREQUENCY LEVEL
US6993385B1 (en) 1999-10-25 2006-01-31 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
AU1049901A (en) 1999-10-25 2001-05-08 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
US7027863B1 (en) 1999-10-25 2006-04-11 Impulse Dynamics N.V. Device for cardiac therapy
US6311087B1 (en) 2000-03-15 2001-10-30 Cardiac Pacemakers, Inc. High-side energy delivery through a single-quadrant thyristor triggered with a current-limiting switch
US6965796B2 (en) 2002-03-11 2005-11-15 Medtronic Physio-Control Manufacturing Corp. Method and apparatus for self-test of defibrillation and pacing circuits including a patient isolation switch
US7096062B2 (en) * 2002-03-11 2006-08-22 Medtronic Physio-Control Manufacturing Corp. Method for self-test of defibrillation and pacing circuits including a patient isolation switch
US6968230B2 (en) 2002-06-26 2005-11-22 Medtronic Physio-Control Manufacturing Corp H-bridge circuit for generating a high-energy biphasic and external pacing waveform in an external defibrillator
US20040044371A1 (en) * 2002-09-04 2004-03-04 Medtronic Physio-Control Manufacturing Corp. Defibrillator with H-bridge output circuit referenced to common ground
US7189204B2 (en) 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
WO2004070396A2 (en) 2003-02-10 2004-08-19 N-Trig Ltd. Touch detection for a digitizer
US7392081B2 (en) * 2003-02-28 2008-06-24 Cardiac Pacemakers, Inc. Subcutaneous cardiac stimulator employing post-shock transthoracic asystole prevention pacing
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US7499750B2 (en) 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Noise canceling cardiac electrodes
US7302294B2 (en) 2003-04-11 2007-11-27 Cardiac Pacemakers, Inc. Subcutaneous cardiac sensing and stimulation system employing blood sensor
US7566318B2 (en) 2003-04-11 2009-07-28 Cardiac Pacemakers, Inc. Ultrasonic subcutaneous dissection tool incorporating fluid delivery
US7865233B2 (en) 2003-04-11 2011-01-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal
US7499758B2 (en) 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Helical fixation elements for subcutaneous electrodes
US7349742B2 (en) * 2003-04-11 2008-03-25 Cardiac Pacemakers, Inc. Expandable fixation elements for subcutaneous electrodes
US7218966B2 (en) 2003-04-11 2007-05-15 Cardiac Pacemakers, Inc. Multi-parameter arrhythmia discrimination
US7555335B2 (en) 2003-04-11 2009-06-30 Cardiac Pacemakers, Inc. Biopotential signal source separation using source impedances
US8116868B2 (en) 2003-04-11 2012-02-14 Cardiac Pacemakers, Inc. Implantable device with cardiac event audio playback
US7979122B2 (en) 2003-04-11 2011-07-12 Cardiac Pacemakers, Inc. Implantable sudden cardiac death prevention device with reduced programmable feature set
US7236819B2 (en) 2003-04-11 2007-06-26 Cardiac Pacemakers, Inc. Separation of a subcutaneous cardiac signal from a plurality of composite signals
US20040204734A1 (en) * 2003-04-11 2004-10-14 Wagner Darrell Orvin Tunneling tool with subcutaneous transdermal illumination
US7570997B2 (en) 2003-04-11 2009-08-04 Cardiac Pacemakers, Inc. Subcutaneous cardiac rhythm management with asystole prevention therapy
US7529592B2 (en) * 2003-04-11 2009-05-05 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with temporary pharmacological agents
US7047071B2 (en) 2003-04-11 2006-05-16 Cardiac Pacemakers, Inc. Patient stratification for implantable subcutaneous cardiac monitoring and therapy
US7389138B2 (en) 2003-04-11 2008-06-17 Cardiac Pacemakers, Inc. Electrode placement determination for subcutaneous cardiac monitoring and therapy
US7702399B2 (en) 2003-04-11 2010-04-20 Cardiac Pacemakers, Inc. Subcutaneous electrode and lead with phoresis based pharmacological agent delivery
US20040230272A1 (en) * 2003-04-11 2004-11-18 Cates Adam W. Subcutaneous lead with temporary pharmacological agents
US20040220626A1 (en) * 2003-04-11 2004-11-04 Wagner Darrell Orvin Distributed subcutaneous defibrillation system
US7493175B2 (en) * 2003-04-11 2009-02-17 Cardiac Pacemakers, Inc. Subcutaneous lead with tined fixation
US7117035B2 (en) 2003-04-11 2006-10-03 Cardiac Pacemakers, Inc. Subcutaneous cardiac stimulation system with patient activity sensing
US7617007B2 (en) 2003-06-04 2009-11-10 Synecor Llc Method and apparatus for retaining medical implants within body vessels
AU2004251673B2 (en) 2003-06-04 2010-01-28 Synecor Llc Intravascular electrophysiological system and methods
US7082336B2 (en) 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
US8239045B2 (en) 2003-06-04 2012-08-07 Synecor Llc Device and method for retaining a medical device within a vessel
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
EP1670547B1 (en) 2003-08-18 2008-11-12 Cardiac Pacemakers, Inc. Patient monitoring system
US7396333B2 (en) 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US8002553B2 (en) 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US20060247693A1 (en) 2005-04-28 2006-11-02 Yanting Dong Non-captured intrinsic discrimination in cardiac pacing response classification
US7774064B2 (en) 2003-12-12 2010-08-10 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
US7747335B2 (en) 2003-12-12 2010-06-29 Synecor Llc Implantable medical device having pre-implant exoskeleton
US8521284B2 (en) 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US20050215884A1 (en) * 2004-02-27 2005-09-29 Greicius Michael D Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US7136702B2 (en) * 2004-03-19 2006-11-14 Medtronic, Inc. Method and apparatus for delivering multi-directional defibrillation waveforms
US7096063B2 (en) * 2004-03-19 2006-08-22 Medtronic, Inc. Method and apparatus for delivering multi-directional defibrillation waveforms
US7706866B2 (en) 2004-06-24 2010-04-27 Cardiac Pacemakers, Inc. Automatic orientation determination for ECG measurements using multiple electrodes
US7805185B2 (en) 2005-05-09 2010-09-28 Cardiac Pacemakers, In. Posture monitoring using cardiac activation sequences
US7890159B2 (en) 2004-09-30 2011-02-15 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring and tracking
US7917196B2 (en) 2005-05-09 2011-03-29 Cardiac Pacemakers, Inc. Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes
US7647108B2 (en) 2004-09-30 2010-01-12 Cardiac Pacemakers, Inc. Methods and systems for selection of cardiac pacing electrode configurations
US7457664B2 (en) 2005-05-09 2008-11-25 Cardiac Pacemakers, Inc. Closed loop cardiac resynchronization therapy using cardiac activation sequence information
US7797036B2 (en) 2004-11-30 2010-09-14 Cardiac Pacemakers, Inc. Cardiac activation sequence monitoring for ischemia detection
US7509170B2 (en) 2005-05-09 2009-03-24 Cardiac Pacemakers, Inc. Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes
US7418293B2 (en) * 2004-11-09 2008-08-26 Cardiac Pacemakers, Inc. Multiple pulse defibrillation for subcutaneous implantable cardiac devices
EP1827571B1 (en) 2004-12-09 2016-09-07 Impulse Dynamics NV Protein activity modification
US8818504B2 (en) 2004-12-16 2014-08-26 Cardiac Pacemakers Inc Leadless cardiac stimulation device employing distributed logic
US7996072B2 (en) * 2004-12-21 2011-08-09 Cardiac Pacemakers, Inc. Positionally adaptable implantable cardiac device
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US7680534B2 (en) 2005-02-28 2010-03-16 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
WO2006097934A2 (en) 2005-03-18 2006-09-21 Metacure Limited Pancreas lead
US7392086B2 (en) 2005-04-26 2008-06-24 Cardiac Pacemakers, Inc. Implantable cardiac device and method for reduced phrenic nerve stimulation
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US7801600B1 (en) 2005-05-26 2010-09-21 Boston Scientific Neuromodulation Corporation Controlling charge flow in the electrical stimulation of tissue
US20070049975A1 (en) * 2005-09-01 2007-03-01 Cates Adam W Active can with dedicated defibrillation and sensing electrodes
US7457662B2 (en) * 2005-09-09 2008-11-25 Cardiac Science Corporation Method and apparatus for variable capacitance defibrillation
US7775983B2 (en) 2005-09-16 2010-08-17 Cardiac Pacemakers, Inc. Rapid shallow breathing detection for use in congestive heart failure status determination
US20070118180A1 (en) * 2005-11-18 2007-05-24 Quan Ni Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection
US7766840B2 (en) 2005-12-01 2010-08-03 Cardiac Pacemakers, Inc. Method and system for heart failure status evaluation based on a disordered breathing index
US7662105B2 (en) * 2005-12-14 2010-02-16 Cardiac Pacemakers, Inc. Systems and methods for determining respiration metrics
US7761158B2 (en) 2005-12-20 2010-07-20 Cardiac Pacemakers, Inc. Detection of heart failure decompensation based on cumulative changes in sensor signals
US7819816B2 (en) 2006-03-29 2010-10-26 Cardiac Pacemakers, Inc. Periodic disordered breathing detection
US20070282376A1 (en) 2006-06-06 2007-12-06 Shuros Allan C Method and apparatus for neural stimulation via the lymphatic system
US8527048B2 (en) 2006-06-29 2013-09-03 Cardiac Pacemakers, Inc. Local and non-local sensing for cardiac pacing
US8948867B2 (en) 2006-09-14 2015-02-03 Cardiac Pacemakers, Inc. Capture detection with cross chamber backup pacing
US8209013B2 (en) 2006-09-14 2012-06-26 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
US8983598B2 (en) * 2006-10-04 2015-03-17 Cardiac Pacemakers, Inc. System for neurally-mediated anti-arrhythmic therapy
US7856265B2 (en) * 2007-02-22 2010-12-21 Cardiac Pacemakers, Inc. High voltage capacitor route with integrated failure point
US8052611B2 (en) 2007-03-14 2011-11-08 Cardiac Pacemakers, Inc. Method and apparatus for management of heart failure hospitalization
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
WO2009094335A1 (en) 2008-01-22 2009-07-30 Cardiac Pacemakers, Inc. Respiration as a trigger for therapy optimization
US8244349B2 (en) * 2008-02-02 2012-08-14 Cameron Health, Inc. Adaptive shock delivery in an implantable cardiac stimulus device
CN101939051B (en) 2008-02-14 2013-07-10 心脏起搏器公司 Method and apparatus for phrenic stimulation detection
US8321014B2 (en) 2008-10-06 2012-11-27 Cardiac Pacemakers, Inc. Dynamic cardiac resynchronization therapy by tracking intrinsic conduction
WO2011075511A2 (en) 2009-12-18 2011-06-23 Cardiac Pacemakers, Inc. Sintered capacitor electrode including multiple thicknesses
EP2513930B1 (en) 2009-12-18 2020-10-07 Cardiac Pacemakers, Inc. Sintered electrodes to store energy in an implantable medical device
US9123470B2 (en) 2009-12-18 2015-09-01 Cardiac Pacemakers, Inc. Implantable energy storage device including a connection post to connect multiple electrodes
US8873220B2 (en) 2009-12-18 2014-10-28 Cardiac Pacemakers, Inc. Systems and methods to connect sintered aluminum electrodes of an energy storage device
WO2011075508A2 (en) 2009-12-18 2011-06-23 Cardiac Pacemakers, Inc. Sintered capacitor electrode including a folded connection
US8725252B2 (en) 2009-12-18 2014-05-13 Cardiac Pacemakers, Inc. Electric energy storage device electrode including an overcurrent protector
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
EP2585824A4 (en) * 2010-04-22 2014-01-01 Kenber Llc Genetic risk analysis in reward deficiency syndrome
US8848341B2 (en) 2010-06-24 2014-09-30 Cardiac Pacemakers, Inc. Electronic component mounted on a capacitor electrode
US9126055B2 (en) 2012-04-20 2015-09-08 Cardiac Science Corporation AED faster time to shock method and device
US10471267B2 (en) 2013-05-06 2019-11-12 Medtronic, Inc. Implantable cardioverter-defibrillator (ICD) system including substernal lead
US10556117B2 (en) 2013-05-06 2020-02-11 Medtronic, Inc. Implantable cardioverter-defibrillator (ICD) system including substernal pacing lead
US10532203B2 (en) 2013-05-06 2020-01-14 Medtronic, Inc. Substernal electrical stimulation system
US9743889B2 (en) 2013-08-05 2017-08-29 Cardiac Pacemakers, Inc. System and method for detecting worsening of heart failure based on rapid shallow breathing index
EP3092034B1 (en) 2014-01-10 2019-10-30 Cardiac Pacemakers, Inc. Systems for detecting cardiac arrhythmias
ES2661718T3 (en) 2014-01-10 2018-04-03 Cardiac Pacemakers, Inc. Methods and systems to improve communication between medical devices
AU2015218603B2 (en) 2014-02-24 2019-12-05 Element Science, Inc External defibrillator
US9782601B2 (en) 2014-04-15 2017-10-10 Cardiac Pacemakers, Inc. Pacing device with autonomous anti-tachycardia pacing
US9526909B2 (en) 2014-08-28 2016-12-27 Cardiac Pacemakers, Inc. Medical device with triggered blanking period
EP3827877A1 (en) 2015-02-06 2021-06-02 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
EP3253449B1 (en) 2015-02-06 2018-12-12 Cardiac Pacemakers, Inc. Systems for safe delivery of electrical stimulation therapy
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
WO2016141046A1 (en) 2015-03-04 2016-09-09 Cardiac Pacemakers, Inc. Systems and methods for treating cardiac arrhythmias
WO2016149262A1 (en) 2015-03-18 2016-09-22 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
US10357159B2 (en) 2015-08-20 2019-07-23 Cardiac Pacemakers, Inc Systems and methods for communication between medical devices
CN108136186B (en) 2015-08-20 2021-09-17 心脏起搏器股份公司 System and method for communication between medical devices
JP6981966B2 (en) 2015-08-26 2021-12-17 エレメント サイエンス, インクElement Science, Inc Wearable device
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10159842B2 (en) 2015-08-28 2018-12-25 Cardiac Pacemakers, Inc. System and method for detecting tamponade
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
US10350423B2 (en) 2016-02-04 2019-07-16 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
CN108883286B (en) 2016-03-31 2021-12-07 心脏起搏器股份公司 Implantable medical device with rechargeable battery
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
CN109414582B (en) 2016-06-27 2022-10-28 心脏起搏器股份公司 Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves
WO2018009569A1 (en) 2016-07-06 2018-01-11 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10391319B2 (en) 2016-08-19 2019-08-27 Cardiac Pacemakers, Inc. Trans septal implantable medical device
US10780278B2 (en) 2016-08-24 2020-09-22 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using P-wave to pace timing
US10870008B2 (en) 2016-08-24 2020-12-22 Cardiac Pacemakers, Inc. Cardiac resynchronization using fusion promotion for timing management
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
US10994145B2 (en) 2016-09-21 2021-05-04 Cardiac Pacemakers, Inc. Implantable cardiac monitor
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
US10758724B2 (en) 2016-10-27 2020-09-01 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
JP7038115B2 (en) 2016-10-27 2022-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with pressure sensor
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
WO2018081275A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
WO2018081721A1 (en) 2016-10-31 2018-05-03 Cardiac Pacemakers, Inc Systems for activity level pacing
CN109890456B (en) 2016-10-31 2023-06-13 心脏起搏器股份公司 System for activity level pacing
WO2018089311A1 (en) 2016-11-08 2018-05-17 Cardiac Pacemakers, Inc Implantable medical device for atrial deployment
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
CN109963618B (en) 2016-11-21 2023-07-04 心脏起搏器股份公司 Leadless cardiac pacemaker with multi-mode communication
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
US11147979B2 (en) 2016-11-21 2021-10-19 Cardiac Pacemakers, Inc. Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
WO2018093605A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
WO2018140623A1 (en) 2017-01-26 2018-08-02 Cardiac Pacemakers, Inc. Leadless device with overmolded components
EP3573706A1 (en) 2017-01-26 2019-12-04 Cardiac Pacemakers, Inc. Intra-body device communication with redundant message transmission
US10737102B2 (en) 2017-01-26 2020-08-11 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
US10946207B2 (en) 2017-05-27 2021-03-16 West Affum Holdings Corp. Defibrillation waveforms for a wearable cardiac defibrillator
WO2019036600A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
US10918875B2 (en) 2017-08-18 2021-02-16 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
CN111107899B (en) 2017-09-20 2024-04-02 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
EP3717063B1 (en) 2017-12-01 2023-12-27 Cardiac Pacemakers, Inc. Systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
EP3717059A1 (en) 2017-12-01 2020-10-07 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
EP3717060B1 (en) 2017-12-01 2022-10-05 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker with reversionary behavior
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
CN111556773A (en) 2018-01-04 2020-08-18 心脏起搏器股份公司 Dual chamber pacing without beat-to-beat communication
WO2019183512A1 (en) 2018-03-23 2019-09-26 Medtronic, Inc. Vfa cardiac resynchronization therapy
CN111886046A (en) 2018-03-23 2020-11-03 美敦力公司 AV-synchronized VFA cardiac therapy
CN111936046A (en) 2018-03-23 2020-11-13 美敦力公司 VFA cardiac therapy for tachycardia
EP3856331A1 (en) 2018-09-26 2021-08-04 Medtronic, Inc. Capture in ventricle-from-atrium cardiac therapy
AU2019357613B2 (en) 2018-10-10 2021-12-09 Element Science, Inc. Wearable medical device with disposable and reusable components
US11951313B2 (en) 2018-11-17 2024-04-09 Medtronic, Inc. VFA delivery systems and methods
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4953551A (en) * 1987-01-14 1990-09-04 Medtronic, Inc. Method of defibrillating a heart
US5083562A (en) * 1988-01-19 1992-01-28 Telectronics Pacing Systems, Inc. Method and apparatus for applying asymmetric biphasic truncated exponential countershocks
EP0553864A2 (en) * 1992-01-30 1993-08-04 Cardiac Pacemakers, Inc. Defibrillator waveform generator for generating waveform of long duration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4821723A (en) * 1987-02-27 1989-04-18 Intermedics Inc. Biphasic waveforms for defibrillation
US4850357A (en) * 1988-01-12 1989-07-25 Cardiac Pacemakers, Inc. Biphasic pulse generator for an implantable defibrillator
US4998531A (en) * 1990-03-28 1991-03-12 Cardiac Pacemakers, Inc. Implantable N-phasic defibrillator output bridge circuit
ATE143280T1 (en) * 1990-12-18 1996-10-15 Ventritex Inc DEVICE FOR PRODUCING CONFIGURABLE TWO-PHASE DEFLAMATION WAVEFORMS
US5275157A (en) * 1991-04-12 1994-01-04 Physio-Control Corporation Pulse forming circuits

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4953551A (en) * 1987-01-14 1990-09-04 Medtronic, Inc. Method of defibrillating a heart
US5083562A (en) * 1988-01-19 1992-01-28 Telectronics Pacing Systems, Inc. Method and apparatus for applying asymmetric biphasic truncated exponential countershocks
EP0553864A2 (en) * 1992-01-30 1993-08-04 Cardiac Pacemakers, Inc. Defibrillator waveform generator for generating waveform of long duration

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733310A (en) * 1996-12-18 1998-03-31 Zmd Corporation Electrotherapy circuit and method for producing therapeutic discharge waveform immediately following sensing pulse
US5769872A (en) * 1996-12-18 1998-06-23 Zmd Corporation Electrotherapy circuit and method for shaping current waveforms
US5797968A (en) * 1996-12-18 1998-08-25 Zmd Corporation Electrotherapy circuit for producing current waveform with sawtooth ripple
US5800463A (en) * 1996-12-18 1998-09-01 Zmd Corporation Electrotherapy circuit having controlled peak current
US5800462A (en) * 1996-12-18 1998-09-01 Zmd Corporation Electrotherapy circuit for producing therapeutic discharge waveform based on high-current sensing pulse
US5904706A (en) * 1996-12-18 1999-05-18 Zmd Corporation Method and apparatus for producing electrotherapy current waveform with ripple
US6096063A (en) * 1996-12-18 2000-08-01 Zmd Corporation Electrotherapy circuit having controlled current discharge based on patient-dependent electrical parameter
WO2009078942A3 (en) * 2007-12-13 2009-08-13 Cardiac Pacemakers Inc Defibrillation shock output circuit
JP2011505967A (en) * 2007-12-13 2011-03-03 カーディアック ペースメイカーズ, インコーポレイテッド Defibrillation shock output circuit
US8116865B2 (en) 2007-12-13 2012-02-14 Cardiac Pacemarkers, Inc. Defibrillation shock output circuit
US8433404B2 (en) 2009-05-19 2013-04-30 Cardiac Pacemakers, Inc. Integrated high voltage output circuit

Also Published As

Publication number Publication date
US5468254A (en) 1995-11-21
AU7328794A (en) 1995-02-20

Similar Documents

Publication Publication Date Title
US5468254A (en) Method and apparatus for defibrillation using a multiphasic truncated exponential waveform
US4637397A (en) Triphasic wave defibrillation
EP0281219B1 (en) Cardiac defibrillator
US4953551A (en) Method of defibrillating a heart
EP0553864B1 (en) Defibrillator waveform generator for generating waveform of long duration
US5531764A (en) Implantable defibrillator system and method having successive changeable defibrillation waveforms
US5411525A (en) Dual capacitor biphasic defibrillator waveform generator employing selective connection of capacitors for each phase
US5522853A (en) Method and apparatus for progressive recruitment of cardiac fibrillation
US4768512A (en) Cardioverting system and method with high-frequency pulse delivery
US5413591A (en) Current truncated waveform defibrillator
US5735879A (en) Electrotherapy method for external defibrillators
EP0476017B1 (en) Defibrillation electrode
US5314448A (en) Process for defibrillation pretreatment of a heart
EP1412026B1 (en) System for applying sequential low energy defibrillation pulses
CA2105749C (en) Fibrillation induction method for implantable devices
US7079894B2 (en) Damped biphasic energy delivery circuit for a defibrillator
US5830236A (en) System for delivering low pain therapeutic electrical waveforms to the heart
US5643323A (en) System and method inducing fibrillation using an implantable defibrillator
Chapman et al. Strength‐Duration Curves of Fixed Pulse Width Variable Tilt Truncated Exponential Waveforms for Nonthoracomy Internal Defibrillation in Dogs
Natale et al. Relative efficacy of different tilts with biphasic defibrillation in humans
Natale et al. Effects of initial polarity on defibrillation threshold with biphasic pulses
EP0547878B1 (en) Defibrillation system with a small capacitor
US6633778B2 (en) High-energy, high-frequency pulse defibrillator
Blanchard et al. The defibrillation waveform
US5342399A (en) Implantable defibrillator system having a small capacitance valve

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA